close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Biotech and Pharmaceuticals Biotechnology Health & Science
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
Tags Novo Nordisk A/S Markets Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Amgen Inc Healthy Returns Health care industry
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
Tags Novo Nordisk A/S Hims & Hers Health Inc Media
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Mad Money Wendys Co Dupont De Nemours Inc
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Trade Novo Nordisk A/S Pfizer Inc
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Biotech and Pharmaceuticals Biotechnology Breaking News: Business
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Bristol/Myers Squibb Co Health care industry Sanofi SA
From CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
Tags Breaking News: Europe Pharmaceuticals Europe News
From CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
Tags Social issues Teladoc Health Inc Hinge Health Inc
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
Tags Stock markets Europe Economy Earnings
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Companies Novo Nordisk A/S Business News
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Healthy Returns Health care industry Novo Nordisk A/S
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Biotech and Pharmaceuticals Biotechnology Eli Lilly and Co
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Healthy Returns Health care industry Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Markets Business Investment strategy
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Hims & Hers Health Inc Business News Companies
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Novo Nordisk A/S Health care industry Healthy Returns
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Health & Science Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Companies Novo Nordisk A/S Business News
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Novo Nordisk A/S Breaking News: Europe Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Novo Nordisk A/S Europe Politics Bayer AG
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Novo Nordisk A/S LILLY DRN Breaking News: Politics
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Health care industry Healthy Returns LILLY DRN
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Business Roche Holding AG AstraZeneca PLC
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It / Money Novo Nordisk A/S Hims & Hers Health Inc
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Health & Science Enterprise Breaking News: Technology
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags stocks DoorDash Inc Affirm Holdings Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Roche Holding AG Mergers Amgen Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today